ENTRY       D04870                      Drug
NAME        Mecasermin rinfabate (USAN/INN);
            Iplex (TN)
FORMULA     C1231H1967N371O384S20
EXACT_MASS  28731.0209
MOL_WEIGHT  28749.345
SEQUENCE    (IGF-I) GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR
            SCDLRRLEMY CAPLKPAKSA
            (IGFBP-3) GASSAGLGPV VRCEPCDARA LAQCAPPPAV CAELVREPGC GCCLTCALSE
            GQPCGIYTER CGSGLRCQPS PDEARPLQAL LDGRGLCVNA SAVSRLRAYL LPAPPAPGNA
            SESEEDRSAG SVESPSVSST HRVSDPKFHP LHSKIIIIKK GHAKDSQRYK VDYESQSTDT
            QNFSSESKRE TEYGPCRREM EDTLNHLKFL NVLSPRGVHI PNCDKKGFYK KKQCRPSKGR
            KRGFCWCVDK YGQPLPGYTT KGKEDVHCYS MQSK
  TYPE      Peptide
REMARK      ATC code: H01AC05
            Chemical structure group: DG01359
            Product (DG01359): D03297<JP/US>
EFFICACY    Antidiabetic, Insulin-like growth factor receptor agonist
TARGET      IGF1R (CD221) [HSA:3480] [KO:K05087]
            GHR [HSA:2690] [KO:K05080]
  PATHWAY   hsa04151(2690+3480)  PI3K-Akt signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
               H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
                H01AC Somatropin and somatropin agonists
                 H01AC05 Mecasermin rinfabate
                  D04870  Mecasermin rinfabate (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                IGF1R (CD221)
                 D04870  Mecasermin rinfabate (USAN/INN)
             Cytokines and receptors
              Cytokine receptors
               CSF and other factor receptors
                GHR
                 D04870  Mecasermin rinfabate (USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04870
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04870
DBLINKS     CAS: 478166-15-3
            PubChem: 47206641
///
